Legal status · United Kingdom
Is Verteporfin legal in the United Kingdom?
Verteporfin is available in the United Kingdom only through a prescriber, classified as "Prescription only". It is not sold over the counter; use sits within a clinician's judgment, not a marketing approval. Vials sold "for research use only" fall outside that route; the label does not make human use lawful. Human evidence: Preliminary.
Verteporfin in the United Kingdom at a glance
| Classification | Prescription only |
|---|---|
| MHRA approval status | Prescription route only; no broad MHRA marketing approval |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Verteporfin profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
Verteporfin reaches patients in the United Kingdom only through a prescriber, typically for a narrow labeled use or via a compounding pharmacy under a prescription.
- 02
That route depends on a clinician's judgment and, for compounded products, on the pharmacy's own quality controls rather than a product-level marketing approval.
- 03
Buying it online "for research use only" is outside that route, and the label does not make human use lawful.
What Verteporfin is
An approved eye drug that, injected into wounds in mice, produced regeneration without scars in a landmark 2021 Science paper; the first human scar trial started in June 2026, and off-label self-use carries days of severe photosensitivity.
Verteporfin is FDA-approved for photodynamic therapy in macular degeneration. Stanford researchers showed that blocking YAP with verteporfin stops Engrailed-1 activation in wound fibroblasts, so mouse wounds heal with hair follicles and glands instead of scar tissue.
Mechanism: Inhibits YAP-TEAD signaling, preventing Engrailed-1 lineage activation in fibroblasts and shifting healing toward regeneration.
Regulatory history: FDA-approved for ocular photodynamic therapy; wound use is investigational (Phase 2)
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Verteporfin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Verteporfin in other countries
United States
Approved medicinePrescription only (approved for eye use); wound use off-label/investigational
Is Verteporfin legal in the United States?Australia
Prescription routePrescription only
Is Verteporfin legal in Australia?Canada
Prescription routePrescription only
Is Verteporfin legal in Canada?Frequently asked questions
Is Verteporfin legal in the United Kingdom?
Verteporfin is available in the United Kingdom only through a prescriber, classified as "Prescription only". It is not sold over the counter; use sits within a clinician's judgment, not a marketing approval. Vials sold "for research use only" fall outside that route; the label does not make human use lawful. Human evidence: Preliminary.
Can I buy Verteporfin in the United Kingdom?
Only through a prescriber. In the United Kingdom Verteporfin is classified as "Prescription only". There is no over-the-counter route, and products sold online "for research use only" are not the same as a prescribed, pharmacy-dispensed product.
Is Verteporfin MHRA approved?
No. In the United Kingdom Verteporfin is classified as "Prescription only", which is not a MHRA marketing approval. For comparison, the US FDA status is: FDA-approved for ocular photodynamic therapy; wound use is investigational (Phase 2). Evidence level: Preliminary.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Verteporfin live on its compound profile.
Verteporfin profileThis page is general information about the regulatory status of Verteporfin in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.